These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 15835606)

  • 1. Incidence of neuritis among paucibacillary leprosy patients during treatment and surveillance.
    John AS
    Indian J Lepr; 2004; 76(3):215-22. PubMed ID: 15835606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
    Richardus JH; Nicholls PG; Croft RP; Withington SG; Smith WC
    Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine.
    Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
    Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results.
    Kroger A; Pannikar V; Htoon MT; Jamesh A; Katoch K; Krishnamurthy P; Ramalingam K; Jianping S; Jadhav V; Gupte MD; Manickam P
    Trop Med Int Health; 2008 May; 13(5):594-602. PubMed ID: 18346026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
    De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
    Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathic pain in people treated for multibacillary leprosy more than ten years previously.
    Saunderson P; Bizuneh E; Leekassa R
    Lepr Rev; 2008 Sep; 79(3):270-6. PubMed ID: 19009976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K; Schreuder PA; Pirayavaraporn C
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of tests for monitoring drug compliance of leprosy out-patients under multi-drug therapy.
    Balakrishnan S; Kumar A; Rao BR; Patro TP
    Indian J Lepr; 1986; 58(4):555-9. PubMed ID: 3572097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.
    Prasad PV; Babu A; Kaviarasan PK; Viswanathan P; Tippoo R
    Indian J Dermatol Venereol Leprol; 2005; 71(4):242-5. PubMed ID: 16394431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of nerve damage in leprosy patients treated with MDT.
    Solomon S; Kurian N; Ramadas P; Rao PS
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):451-6. PubMed ID: 10347565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy trial in paucibacillary leprosy using clofazimine.
    Katoch K; Natarajan M; Katoch VM; Singh HB; Bhatia AS
    Indian J Lepr; 1999; 71(3):311-24. PubMed ID: 10626237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed duration MDT in paucibacillary leprosy (classical and modified).
    Nadkarni NJ; Grugni A; Kini MS
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):25-8. PubMed ID: 8326177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disabilities in multibacillary leprosy patients: before, during and after multidrug therapy.
    Sharma P; Kar HK; Beena KR; Kaur H; Narayan R
    Indian J Lepr; 1996; 68(2):127-36. PubMed ID: 8835580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.